Symbiotec Pharmalab gets Rs 526 crore anchor backing ahead of IPO; Citi Group, Singularity among investors
2 sources·Updated August 21, 2026
Covered by 2 sources
- Business Standard·9h agoSymbiotec Pharmalab raises ₹526 cr from anchor investors; IPO opens Aug 24
Pharma and biotech company Symbiotec Pharmalab Ltd on Friday raised Rs 526 crore from anchor investors days before the opening of its initial public offering (IPO).
Read at Business Standard → - ET Markets·10h agoSymbiotec Pharmalab gets Rs 526 crore anchor backing ahead of IPO; Citi Group, Singularity among investors
Symbiotec Pharmalab has raised Rs 526.20 crore from anchor investors ahead of its Rs 1,757 crore IPO opening August 24. The pharmaceutical company has set a Rs 938-988 price band, with proceeds from the fresh issue earmarked for debt repayment.
Read at ET Markets →
